Jason Aldred

Also affiliated with Neurology, Inc

MedicineHealth ProfessionsNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study”.

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurology and Therapy(2023)10.1007/s40120-023-00533-1

N/A

5.3DataRank · unranked

122 citations

Eric Freire-Álvarez, А. В. Амелин, Angelo Antonini, Bruno Bergmans, Filip Bergquist +17 more

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

JAMA(2021)10.1001/jama.2021.10207

N/A

4.5DataRank · unranked

160 citations

Brent Bluett, Daniel M. Togasaki, Dragos Mihaila, Marian L. Evatt, Michael Rezak +95 more

Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results

Journal of Parkinson s Disease(2023)10.3233/jpd-225105

N/A

0.945DataRank · unranked

37 citations

Norbert Kovács, Francesco E. Pontieri, Jason Aldred, Paul Bourgeois, Thomas L. Davis +12 more

Sustained Therapeutic Benefits Using Image‐Guided Programming at Activation of Deep Brain Stimulation for Parkinson's Disease

Movement Disorders Clinical Practice(2025)10.1002/mdc3.70154

N/A

0.208DataRank · unranked

3 citations

Theresa Zesiewicz, Michael S. Okun, Adolfo Ramirez‐Zamora, Okeanis E. Vaou, Leo Verhagen Metman +16 more

Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel

Journal of Parkinson s Disease(2021)10.3233/jpd-212979

N/A

0DataRank · unranked

16 citations

Lars Bergmann, Marieta Anca-Herschkovitsch, Esther Cubo, Thomas L. Davis, Robert Iansek +10 more

DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease

Movement Disorders Clinical Practice(2021)10.1002/mdc3.13239

N/A

0DataRank · unranked

44 citations

Jason Aldred, Marieta Anca‐Herschkovitsch, Paul Bourgeois, Esther Cubo, Thomas L. Davis +10 more

Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients

Fluids and Barriers of the CNS(2020)10.1186/s12987-019-0164-3

N/A

0DataRank · unranked

38 citations

Mohammad Reza Khani, Jacob Romm, Marianne Schmid Daners, Kyle McCain, Tavara Freeman +7 more